![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
THERAPEUTICAL NOTES
Minerva Gastroenterologica e Dietologica 1999 March;45(1):59-76
Copyright © 1999 EDIZIONI MINERVA MEDICA
language: Italian
Topical beclomethasone dipropionate (BDP) in intestinal inflammatory diseases: the results of a multicentre trial
Borzio M., Borzio F., Milano G., Biraghi M., Cestari L., Ravelli P., de Franchis R., Vecchi M., Minoli G., Prada A., Curzio M., Galeone M., Toti G. L., Cacioli D., Megevand J.
Full text temporarily not available online. Contact us
The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.